Navigation Links
MODA Announces Availability of Third Generation Mobile Data Acquisition Platform

WAYNE, Pa., Dec. 14 /PRNewswire/ -- MODA Technology Partners, a global software company that automates environmental monitoring (EM), utility and product testing for the Pharmaceutical industry, today announced the general availability of MODA 3.0, the company's third generation mobile data acquisition platform. The latest release enables quality control (QC) organizations to further automate their regulated manufacturing processes.

MODA 3.0 includes the following new capabilities:

  • Fully-Configurable Test Methods: Each test method in the MODA 3.0 library contains configurable business rules that define workflow steps, associated equipment and media, measurement readings and calculated results. Configurations also support establishment of standard action and alert levels, as well as frequency-based rules (i.e. three alerts in a row = one action). Technicians can easily set up any type of test on their own--tailored to their specific Standard Operating Procedures (SOPs). This new feature boosts the entire QC Micro operation across all EM, utility, and product tests. Additionally, direct configurations by the technicians allow their organizations to move quickly into production and easily maintain the system in a validated environment through a simple change control process.
  • New Device Integration: The MODA platform now integrates with additional air and water testing devices used in and out of today's clean rooms and labs, thus eliminating manual, paper-based transcription and verification tasks that are error-prone and labor-intensive.
  • Media Growth Promotion: MODA 3.0 now manages this common test methodology with built-in checks that tie final approval to only those records where associated media lots have passed their growth promotion test.
  • Group Barcoding & Assay Assignment: MODA 3.0 now enables technicians to organize and label test sample groups via barcode for improved usability.
  • Enhanced Reporting, Trending & Analysis: Technicians can now spot adverse trends faster so that corrective and preventive actions can be taken sooner to better meet internal and external audit requirements.

"Following several successful deployments of our new platform in 2009," said Michael Goetter, Vice President of Product Strategy at MODA, "we are pleased to see the life sciences industry continuing its efforts to adopt the critical automation concepts promoted by organizations like the Parenteral Drug Association. We believe that MODA-EM(TM) and other solutions that embrace these concepts can play a significant role in improving the market for years to come."

About MODA

More science. Less paper. MODA Technology Partners ( provides a mobile data acquisition platform that enables quality assurance and quality control organizations in the Life Sciences industry to automate their regulated manufacturing processes, including environmental monitoring (EM), utility testing, and product testing. MODA's flagship software, MODA-EM(TM), is a paperless QC Micro solution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality, and reduced costs. MODA enables companies to advance their Green Initiatives by reducing and eventually eliminating the need for paper-based, labor-intensive EM programs. MODA is headquartered in Wayne, Pennsylvania with authorized resellers and technology integration partners throughout North America and Europe.

SOURCE MODA Technology Partners

SOURCE MODA Technology Partners
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. ESHRE announces its campus workshop: Artificial Insemination: An Update
2. Lupus Research Institute announces 2009 novel research grants
3. NanoString Technologies announces research collaboration with the Broad Institute
4. Aware, Inc. Announces Support for New ITU Testing Standard with Line Diagnostics Platform
5. PDC Biotech GmbH Announces Close of Series A Financing
6. SCM Microsystems Announces Results of Annual Meeting
7. Columbia University Medical Center announces 2009 Katz Prizes in Cardiovascular Research
8. Synaptics Announces Put Option for 0.75% Convertible Senior Subordinated Notes Due 2024
9. DigitalPersona Announces Windows 7 Support for Its Enterprise, Developer and Consumer Products
10. Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
11. NIH announces 115 awards to encourage high-risk research and innovation
Post Your Comments:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology: